Prophylactic VA-ECMO During Complex High-Risk PCI

Chenliang Pan, Youqi Zhu, Jing Zhao, Bo Zhang, Sixiong Hu, Cunrui Zhao, Xiaoxue Meng, Xinghu Zhou, Yan Su, Eric P. Xing, Lei Peng, Nan Bai, Juan Ma, Xiaojuan Wang, Andong Lu, Ming BaiJACC 2025 · DOI

TL;DR

This study investigated the use of prophylactic venoarterial extracorporeal membrane oxygenation (VA-ECMO) during complex high-risk percutaneous coronary interventions (PCI). The findings suggest that prophylactic VA-ECMO significantly reduces life-threatening complications during the procedure and leads to a greater reduction in coronary lesion complexity scores, offering a potential new strategy for managing high-risk PCI patients.

What Problem Does This Paper Address?

Percutaneous coronary intervention (PCI) is a common procedure to treat coronary artery disease. However, for patients with complex and high-risk coronary lesions, PCI carries a significant risk of serious complications, including cardiac arrest, cardiogenic shock, and acute left heart failure. Current guidelines do not offer explicit recommendations for hemodynamic support during these high-risk PCI procedures. While mechanical circulatory support (MCS) devices like VA-ECMO are known to be effective in emergencies, their prophylactic use before such high-risk PCI procedures to prevent complications and improve outcomes has been largely unexplored, with limited randomized controlled trial data available. This paper aims to fill this gap by evaluating the safety and efficacy of prophylactic VA-ECMO in this specific patient population.

Methods

This was a prospective, single-center, randomized controlled trial that enrolled 70 patients with complex high-risk coronary lesions (defined by a Synergy Between PCI with Taxus and Cardiac Surgery [SYNTAX] score ≥33) who had declined coronary artery bypass grafting (CABG). Patients were randomly assigned to either a prophylactic VA-ECMO group (n=34) or a control group (n=36) that did not receive prophylactic VA-ECMO.

In the VA-ECMO group, VA-ECMO support was initiated before the PCI procedure. In the control group, standard procedures were followed, with VA-ECMO equipment prepared and kept on standby for emergency use if life-threatening complications arose during PCI. All patients underwent elective PCI.

The primary safety endpoint was the rate of life-threatening complications during PCI, defined as cardiac arrest unresponsive to resuscitation, cardiogenic shock, acute left heart failure unresponsive to therapy, or refractory malignant arrhythmias. The primary efficacy endpoint was the reduction in SYNTAX score achieved post-PCI. Secondary endpoints included major adverse cardiac and cerebrovascular events (MACCES) at 1 and 12 months post-PCI.

Datasets

Not discussed in the paper. The study utilized patient data collected during the clinical trial.

Key Insights and Ideas

  • Prophylaxis is Key: The most striking finding is that prophylactic VA-ECMO (given before PCI) completely eliminated life-threatening complications during the procedure in the VA-ECMO group, whereas 19.4% of the control group experienced such events. This strongly suggests that preemptive hemodynamic support can prevent severe adverse outcomes.
  • Beyond Low LVEF: While low left ventricular ejection fraction (LVEF) is a known risk factor, the study highlights that even patients with normal or near-normal LVEF can be at high risk for hemodynamic instability during complex PCI due to factors like anatomical complexity. This broadens the potential patient population who might benefit from prophylactic support.
  • Improved Revascularization: The VA-ECMO group showed a significantly greater absolute reduction in SYNTAX scores post-PCI. This indicates that with the hemodynamic stability provided by VA-ECMO, interventional cardiologists were able to achieve more complete revascularization, potentially leading to better long-term outcomes.
  • No Short-Term MACCE Difference: Despite the significant reduction in acute complications, there was no statistically significant difference in MACCE rates between the groups at 1 and 12 months post-PCI. This suggests that while VA-ECMO excels at preventing immediate procedural catastrophes, its impact on longer-term clinical events may require larger studies to detect.

Key Results

  • Life-Threatening Complications: The rate of life-threatening complications during PCI was significantly lower in the VA-ECMO group (0%) compared to the control group (19.4%; P = 0.01).
  • Emergency VA-ECMO: Seven patients (19.4%) in the control group required emergency VA-ECMO during PCI.
  • SYNTAX Score Reduction: The VA-ECMO group demonstrated a greater absolute reduction in SYNTAX scores post-PCI (27.2 vs. 22.5; P = 0.04).
  • MACCE: No significant difference in MACCE incidence was observed between the groups at 1-month (5.9% vs. 11.1%; P = 0.67) or 12-month (5.9% vs. 16.7%; P = 0.26) follow-up.
  • Hospital Stay: Patients in the VA-ECMO group had significantly longer hospital stays (coronary care unit: 7.0 vs. 3.5 days; total: 12.0 vs. 8.0 days).

Limitations and Future Work

The authors acknowledge several limitations:

  • Small Sample Size: The study was conducted at a single center with a relatively small sample size (n=70), which limits the generalizability of the findings and the statistical power to detect differences, particularly in longer-term outcomes.
  • Operator Expertise: All procedures were performed by experienced interventional cardiologists, and the results may not be directly transferable to centers with less expertise in complex PCI or VA-ECMO management.
  • Absent Echocardiographic Follow-up: The lack of post-PCI echocardiographic data limits the evaluation of long-term cardiac function effects.

The authors emphasize the need for larger, multicenter studies to confirm these findings, better understand the benefits and risks of VA-ECMO in complex high-risk PCI, and to further define optimal management strategies for this challenging patient population. Future research should also focus on evaluating the long-term impact of VA-ECMO on cardiac function and clinical outcomes.

Summary updated

Abstract

In this single-center study of patients undergoing elective PCI of complex high-risk coronary lesions, prophylactic VA-ECMO was associated with lower rates of life-threatening complications and larger reduction in SYNTAX scores. Larger studies are needed to further define optimal management strategies in high-risk complex PCI.
BibTeX
@inproceedings{pan2025prophylactic,
  author = {Chenliang Pan and Youqi Zhu and Jing Zhao and Bo Zhang and Sixiong Hu and Cunrui Zhao and Xiaoxue Meng and Xinghu Zhou and Yan Su and Eric P. Xing and Lei Peng and Nan Bai and Juan Ma and Xiaojuan Wang and Andong Lu and Ming Bai},
  title = {{Prophylactic VA-ECMO During Complex High-Risk PCI}},
  booktitle = {JACC},
  year = {2025},
  doi = {10.1016/j.jacadv.2025.102095},
}
Figure